Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03906617 · ClinicalTrials.gov registry record · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
A Phase 4 study of Robotic Lung Surgery, sponsored by The Cooper Health System.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT03906617: Recruiting Phase 4 study of Robotic Lung Surgery, sponsored by The Cooper Health System.
NCT03906617 is a Phase 4 study of Robotic Lung Surgery that is actively recruiting participants, run by The Cooper Health System. The registered enrollment target is 34 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03906617, a Phase 4 study of Robotic Lung Surgery, is actively recruiting participants, sponsored by The Cooper Health System.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.
Conditions Studied
Interventions
- DRUG Intercostal nerve block and wound infiltration with liposomal bupivacaine
- DRUG Intercostal nerve block and wound infiltration with bupivacaine/epinephrine + dexamethasone
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-04-10 |
| Est. Completion | 2022-06-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03906617
The ClinicalTrials.gov registry entry for NCT03906617 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Robotic Lung Surgery appearing as the primary indexed condition, and to 2 interventions - of which Intercostal nerve block and wound infiltration with liposomal bupivacaine is the first listed.
NCT03906617 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT03906617 about?
NCT03906617 is a clinical study titled "Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine". This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been ...
What is the current status of trial NCT03906617?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2019-04-10. Estimated completion is 2022-06-10.
What conditions does trial NCT03906617 study?
This clinical trial studies the following conditions: Robotic Lung Surgery.
What interventions are being tested in trial NCT03906617?
The interventions under investigation include: Intercostal nerve block and wound infiltration with liposomal bupivacaine (DRUG), Intercostal nerve block and wound infiltration with bupivacaine/epinephrine + dexamethasone (DRUG).
Who is sponsoring clinical trial NCT03906617?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03906617 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.